Qui sommes-nous ?
THE FOUNDER
Benoît Serive
CEO, Scientific & Technical Director
Dr. Benoît SERIVE has been passionate about marine biodiversity and health issues for many years. He has been working in the field of marine bioresources valorization since 1997.
Starting with a vocational training certificate in Marine Cultures through an apprenticeship, he supplemented his skills through an unconventional curriculum that led him to a Ph.D. in marine pharmacognosy and oceanography in 2012.
He then set up and won a European Marie Curie research program (OCEANChArCoT) for postdoctoral research in Australia at the Griffith Institute for Drug Discovery.
Throughout his career, Benoît has been the recipient of the 2006 vocation award from the Marcel Bleustein Blanchet Foundation, which strengthened his determination to achieve the projects that he holds dear.
Moreover, he has developed expertise in marine molecules of interest to human health since 2006, and more specific expertise in marine pigments since 2009.
Intent on infusing a lot of meaning and human values into a marine biotechnology project, he created the company BlueCare Discovery in 2022 with the support of the impact-driven startup studio Imagination Machine.
Board of Directors
Rob Spiro
Director of the startup studio Imagination Machine & Investor
Rob is a serial entrepreneur from California. He co-founded Aadvark before being acquired by Google where he worked on Google+ and Google Hangouts. Rob then founded the startup Good Eggs.
Today Rob is the founder and director of the Nantes-based impact startup studio Imagination Machine, where he has co-created successful startups in recent years such as Beem, Les Mini Mondes, and Smala.
Stéphane Janin
Finance and Business Development Committee
Stéphane has 24 years of experience in several major international groups (Crown and Cargill). He has held executive positions in Corporate Development, Finance, and Commercial in France, Belgium, and the United States.
After completing technical and business studies, he furthered his education with a Mini-MBA at McKinsey & Company and finance training at the ESCP Business School.
He brings a business-oriented and international approach, along with a broad strategic perspective, to the development of BlueCare Discovery.
Hervé Jullien de Pommerol
Chief Operation Officer
Hervé is a seasoned drug development leader with 25+ years of international experience across all stages of development, including strategic roles at Novartis
He founded Spes Bioventure to support start-ups and biotechs, leveraging his expertise in Target Product Profiles, cross-functional program strategy, clinical study design, and drug registration.
He also has deep experience in asset evaluation and portfolio management.
Strategic Advisors
Hervé Jullien
Coach executif
Hervé brings a wide-ranging and in-depth knowledge of the healthcare industry, acquired over many years at Sanofi and Rhone-Poulenc in particular. An engineer by training, he also holds an MBA. He began his career in R&D, before moving on to management positions in the fields of marketing international operations and strategy. He was also Director of Strategy for Sanofi vaccines.
Today, as executive coach and strategy consultant, he helps entrepreneurs realize their ambitions.
Sylvain Josse
Expert in Pharmaceutical Development and CMC
Sylvain is a chemical engineer and healthcare entrepreneur. He heads the HC NEXT consultancy HC NEXT. He has participated in the development of several drug candidates, some of which are now approved for market. Its expertise lies in pharmaceutical drug development.
He is a member of the EIT Health jury.
OUR COMMITMENTS
Sustainable development
Among chronic diseases, there are those related to neurodegeneration. The UN has set Sustainable Development Goals (SDGs) to contribute to a better world tomorrow.
And BlueCare is firmly committed to contributing through its activities.
ODD3
Good health and well-being
By developing innovative bioactive compounds, BlueCare contributes to the health revolution towards the management of diseases before the first symptoms appear.
ODD9
Industry, innovation and infrastructure
Ultimately, with its bioplatform, BlueCare will offer solutions for various applications (dermatocosmetics, nutraceuticals, etc.), thereby contributing to the development of the enormous economic potential of the sector.
ODD12
Responsible consumption and production
BlueCare is committed to optimizing the use of the biomass it produces. The various microalgae bioproducts are relevant biosourced alternatives to petrochemical ingredients.
ODD13
Measures to combat climate change
Marine microalgae cultivation is by nature a virtuous biomass production method: no insecticides or pesticides from petrochemicals, no competition with drinking water needs, and yields up to 3x higher than terrestrial crops.
ODD14
Aquatic life
One Health – BlueCare embodies the era of sustainable “drug discovery”: the molecules developed must be stable and effective enough to reach their target without disrupting the environment once they have been expelled by the treated organism.
CSR Commitment
BlueCare’s CSR commitments don’t stop at the UN’s SDGs.
At BlueCare, quality of life at work and between all people is essential. Everyone should be able to thrive in their daily mission and work in a peaceful environment.
Key values
Among all that characterizes us, we are fiercely committed to the simplicity of relationships, open-mindedness, integrity, and kindness. It’s not optional, life is far too short to spoil it!
We will give our best to ensure your experience with us is as good as possible.